BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20823161)

  • 21. Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.
    Shehata M; Schnabl S; Demirtas D; Hilgarth M; Hubmann R; Ponath E; Badrnya S; Lehner C; Hoelbl A; Duechler M; Gaiger A; Zielinski C; Schwarzmeier JD; Jaeger U
    Blood; 2010 Oct; 116(14):2513-21. PubMed ID: 20576813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.
    Stachelscheid J; Jiang Q; Aszyk C; Warner K; Bley N; Müller T; Vydzhak O; Symeonidis K; Crispatzu G; Mayer P; Blakemore SJ; Goehring G; Newrzela S; Hippler S; Robrecht S; Kreuzer KA; Pallasch C; Krüger M; Lechner A; Fischer K; Stilgenbauer S; Beutner D; Hallek M; Auguin D; Hüttelmaier S; Bloehdorn J; Vasyutina E; Herling M
    Blood; 2023 Mar; 141(12):1425-1441. PubMed ID: 36179280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.
    Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C
    Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.
    Jones DT; Ganeshaguru K; Anderson RJ; Jackson TR; Bruckdorfer KR; Low SY; Palmqvist L; Prentice HG; Hoffbrand AV; Mehta AB; Wickremasinghe RG
    Blood; 2003 Apr; 101(8):3174-80. PubMed ID: 12480711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1.
    Schrader A; Popal W; Lilienthal N; Crispatzu G; Mayer P; Jones D; Hallek M; Herling M
    Curr Cancer Drug Targets; 2014; 14(8):700-12. PubMed ID: 25348018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
    Zurli V; Wimmer G; Cattaneo F; Candi V; Cencini E; Gozzetti A; Raspadori D; Campoccia G; Sanseviero F; Bocchia M; Baldari CT; Kabanova A
    Blood; 2017 Nov; 130(18):2006-2017. PubMed ID: 28931525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
    Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
    Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
    Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
    Ghosh AK; Kay NE; Secreto CR; Shanafelt TD
    Clin Cancer Res; 2009 Feb; 15(4):1250-8. PubMed ID: 19228728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.
    Hu X; Haney N; Kropp D; Kabore AF; Johnston JB; Gibson SB
    J Biol Chem; 2005 Mar; 280(10):9498-508. PubMed ID: 15618220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transduction inhibitors in chronic lymphocytic leukemia.
    Ma S; Rosen ST
    Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
    McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
    Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
    Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
    Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
    Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
    Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment.
    Shen Y; Crassini K; Sandhu S; Fatima N; Christopherson RI; Mulligan SP; Best OG
    Leuk Lymphoma; 2019 Jul; 60(7):1632-1643. PubMed ID: 30648436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
    De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
    Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.
    Hofbauer SW; Krenn PW; Ganghammer S; Asslaber D; Pichler U; Oberascher K; Henschler R; Wallner M; Kerschbaum H; Greil R; Hartmann TN
    Blood; 2014 Apr; 123(14):2181-8. PubMed ID: 24501217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia.
    Martins LR; Lúcio P; Silva MC; Anderes KL; Gameiro P; Silva MG; Barata JT
    Blood; 2010 Oct; 116(15):2724-31. PubMed ID: 20660292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
    Bhalla S; Gordon LI
    Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.
    Seda V; Vojackova E; Ondrisova L; Kostalova L; Sharma S; Loja T; Mladonicka Pavlasova G; Zicha D; Kudlickova Peskova M; Krivanek J; Liskova K; Kren L; Benes V; Musilova Litzmanova K; Borsky M; Oppelt J; Verner J; Pospisilova S; Brychtova Y; Panovska A; Tan Z; Zhang S; Doubek M; Amruz Cerna K; Mayer J; Mraz M
    Blood; 2021 Sep; 138(9):758-772. PubMed ID: 33786575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.